Nishi, Yuki
Toritsuka, Michihiro https://orcid.org/0000-0001-6891-4173
Takada, Ryohei
Ishikawa, Mitsuru
Ishida, Rio
Kayashima, Yoshinori
Yamauchi, Takahira
Okumura, Kazuki https://orcid.org/0000-0002-3019-7049
Takeda, Tsutomu
Yamamuro, Kazuhiko https://orcid.org/0000-0002-4362-3262
Ikehara, Minobu
Noriyama, Yuki
Kamikawa, Kohei
Murayama, Shuhei
Ichikawa, Osamu
Nagata, Hidetaka https://orcid.org/0000-0003-4109-7657
Okano, Hideyuki https://orcid.org/0000-0001-7482-5935
Iwata, Nakao https://orcid.org/0000-0003-3189-6076
Makinodan, Manabu
Article History
Received: 11 June 2024
Revised: 4 March 2025
Accepted: 26 March 2025
First Online: 4 April 2025
Competing interests
: Dr. Makinodan received research support from Sumitomo Pharma. Dr. Murayama, Dr. Ichikawa, and Dr. Nagata are employees of Sumitomo Pharma Co., Ltd. The remaining authors declare no conflict of interest.